|
|
Identification |
|
Name |
|
Vedroprevir |
|
Synonyms |
|
(1R,2R)-N-[[(1alpha,3beta,5alpha)-Bicyclo[3.1.0]hex-3-yloxy]carbonyl]-3-methyl-L-valyl-(4R)-4-[[8-chloro-2-[2-[(1-methylethyl)amino]-4-thiazolyl]-7-[2-(4-morpholinyl)ethoxy]-4-quinolinyl]oxy]-L-prolyl-1-amino-2-ethyl-cyclopropanecarboxylic acid; GS 9451 |
|
|
Molecular Structure |
|
![CAS # 1098189-15-1 (1310824-24-8), Vedroprevir, (1R,2R)-N-[[(1alpha,3beta,5alpha)-Bicyclo[3.1.0]hex-3-yloxy]carbonyl]-3-methyl-L-valyl-(4R)-4-[[8-chloro-2-[2-[(1-methylethyl)amino]-4-thiazolyl]-7-[2-(4-morpholinyl)ethoxy]-4-quinolinyl]oxy]-L-prolyl-1-amino-2-ethyl-cyclopropanecarboxylic acid, GS 9451](/structures/1098189-15-1.gif) |
|
|
Molecular Formula |
|
C45H60ClN7O9S |
|
Molecular Weight |
|
910.52 |
|
CAS Registry Number |
|
1098189-15-1 (1310824-24-8) |
| |
|
Properties |
|
|
Solubility |
|
Insoluble (5.8E-4 g/L) (25 ºC), Calc.* |
|
Density |
|
1.38±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
| |
|
|
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)
|
|
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
